177 related articles for article (PubMed ID: 33161412)
1. Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.
Tavares V; Pinto R; Assis J; Coelho S; Brandão M; Alves S; Pereira D; Medeiros R
Pharmacogenomics J; 2021 Apr; 21(2):222-232. PubMed ID: 33161412
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour.
Tavares V; Pinto R; Assis J; Pereira D; Medeiros R
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188331. PubMed ID: 31689458
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort.
Pinto R; Assis J; Nogueira A; Pereira C; Coelho S; Brandão M; Dias J; Alves S; Pereira D; Medeiros R
Pharmacogenomics J; 2019 Feb; 19(1):25-32. PubMed ID: 30287910
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism-related genetic determinant F11 rs4253417 is a potential prognostic factor in ischaemic stroke.
Tavares V; Assis J; Pinto R; Freitas-Silva M; Medeiros R
Mol Cell Probes; 2023 Aug; 70():101917. PubMed ID: 37364690
[TBL] [Abstract][Full Text] [Related]
5. Rethinking ovarian cancer genomics: where genome-wide association studies stand?
Pinto R; Assis J; Nogueira A; Pereira C; Pereira D; Medeiros R
Pharmacogenomics; 2017 Nov; 18(17):1611-1625. PubMed ID: 29095100
[TBL] [Abstract][Full Text] [Related]
6. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
[TBL] [Abstract][Full Text] [Related]
7. Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population.
Zhang HB; Zeng Y; Li TL; Wang G
Genomics; 2020 May; 112(3):2510-2515. PubMed ID: 32045670
[TBL] [Abstract][Full Text] [Related]
8. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.
Lu Y; Beeghly-Fadiel A; Wu L; Guo X; Li B; Schildkraut JM; Im HK; Chen YA; Permuth JB; Reid BM; Teer JK; Moysich KB; Andrulis IL; Anton-Culver H; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Benitez J; Bjorge L; Brenton J; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Claes KBM; Couch FJ; Cramer DW; Daly MB; deFazio A; Dennis J; Diez O; Domchek SM; Dörk T; Easton DF; Eccles DM; Fasching PA; Fortner RT; Fountzilas G; Friedman E; Ganz PA; Garber J; Giles GG; Godwin AK; Goldgar DE; Goodman MT; Greene MH; Gronwald J; Hamann U; Heitz F; Hildebrandt MAT; Høgdall CK; Hollestelle A; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James P; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Kwong A; Le ND; Leslie G; Lesueur F; Levine DA; Mattiello A; May T; McGuffog L; McNeish IA; Merritt MA; Modugno F; Montagna M; Neuhausen SL; Nevanlinna H; Nielsen FC; Nikitina-Zake L; Nussbaum RL; Offit K; Olah E; Olopade OI; Olson SH; Olsson H; Osorio A; Park SK; Parsons MT; Peeters PHM; Pejovic T; Peterlongo P; Phelan CM; Pujana MA; Ramus SJ; Rennert G; Risch H; Rodriguez GC; Rodríguez-Antona C; Romieu I; Rookus MA; Rossing MA; Rzepecka IK; Sandler DP; Schmutzler RK; Setiawan VW; Sharma P; Sieh W; Simard J; Singer CF; Song H; Southey MC; Spurdle AB; Sutphen R; Swerdlow AJ; Teixeira MR; Teo SH; Thomassen M; Tischkowitz M; Toland AE; Trichopoulou A; Tung N; Tworoger SS; van Rensburg EJ; Vanderstichele A; Vega A; Edwards DV; Webb PM; Weitzel JN; Wentzensen N; White E; Wolk A; Wu AH; Yannoukakos D; Zorn KK; Gayther SA; Antoniou AC; Berchuck A; Goode EL; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
Cancer Res; 2018 Sep; 78(18):5419-5430. PubMed ID: 30054336
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
[TBL] [Abstract][Full Text] [Related]
10. Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Carvalho L; Salgado L; Pereira D; Medeiros R
Sci Rep; 2023 Jun; 13(1):9519. PubMed ID: 37308506
[TBL] [Abstract][Full Text] [Related]
11. Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer.
Xu Y; Cheng L; Dai H; Zhang R; Wang M; Shi T; Sun M; Cheng X; Wei Q
J Cell Mol Med; 2018 Oct; 22(10):4975-4984. PubMed ID: 30055028
[TBL] [Abstract][Full Text] [Related]
12. HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer.
Schwich E; Rebmann V; Michita RT; Rohn H; Voncken JW; Horn PA; Kimmig R; Kasimir-Bauer S; Buderath P
Sci Rep; 2019 Apr; 9(1):5407. PubMed ID: 30932005
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.
Tang W; Teichert M; Chasman DI; Heit JA; Morange PE; Li G; Pankratz N; Leebeek FW; Paré G; de Andrade M; Tzourio C; Psaty BM; Basu S; Ruiter R; Rose L; Armasu SM; Lumley T; Heckbert SR; Uitterlinden AG; Lathrop M; Rice KM; Cushman M; Hofman A; Lambert JC; Glazer NL; Pankow JS; Witteman JC; Amouyel P; Bis JC; Bovill EG; Kong X; Tracy RP; Boerwinkle E; Rotter JI; Trégouët DA; Loth DW; Stricker BHC; Ridker PM; Folsom AR; Smith NL
Genet Epidemiol; 2013 Jul; 37(5):512-521. PubMed ID: 23650146
[TBL] [Abstract][Full Text] [Related]
14. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
[TBL] [Abstract][Full Text] [Related]
15. Is there still room for additional common susceptibility alleles for venous thromboembolism?
Trégouët DA; Delluc A; Roche A; Derbois C; Olaso R; Germain M; de Andrade M; Tang W; Chasman DI; van Hylckama Vlieg A; Reitsma PH; Kabrhel C; Smith N; Morange PE
J Thromb Haemost; 2016 Sep; 14(9):1798-802. PubMed ID: 27326655
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in
Si W; Kang S; Sun H; Chen J; Cao S; Li Y
Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
18. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
Li Y; Zhang HL; Kang S; Zhou RM; Wang N
Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.
Germain M; Chasman DI; de Haan H; Tang W; Lindström S; Weng LC; de Andrade M; de Visser MC; Wiggins KL; Suchon P; Saut N; Smadja DM; Le Gal G; van Hylckama Vlieg A; Di Narzo A; Hao K; Nelson CP; Rocanin-Arjo A; Folkersen L; Monajemi R; Rose LM; Brody JA; Slagboom E; Aïssi D; Gagnon F; Deleuze JF; Deloukas P; Tzourio C; Dartigues JF; Berr C; Taylor KD; Civelek M; Eriksson P; ; Psaty BM; Houwing-Duitermaat J; Goodall AH; Cambien F; Kraft P; Amouyel P; Samani NJ; Basu S; Ridker PM; Rosendaal FR; Kabrhel C; Folsom AR; Heit J; Reitsma PH; Trégouët DA; Smith NL; Morange PE
Am J Hum Genet; 2015 Apr; 96(4):532-42. PubMed ID: 25772935
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
